JENNIFER FRAUSTO: Open Payments
NPI 1205268513 · CASPER, WY. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$1,689 in 103 payments from 13 companies in 2025. Trend: 2023 $1,773 · 2024 $1,355 · 2025 $1,689
Food & beverage: $1,486Education: $203
| Company | Payments | Amount |
|---|---|---|
| Alkermes, Inc. | 22 | $257 |
| Teva Pharmaceuticals USA, Inc. | 6 | $254 |
| Lundbeck LLC | 16 | $253 |
| ABBVIE INC. | 19 | $245 |
| Otsuka America Pharmaceutical, Inc. | 11 | $217 |
| ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) | 14 | $151 |
| Collegium Pharmaceutical, Inc. | 5 | $100 |
| Neurocrine BioSciences, Inc. | 3 | $69 |
| Supernus Pharmaceuticals, Inc. | 2 | $48 |
| Takeda Pharmaceuticals U.S.A., Inc. | 2 | $42 |
Products named: REXULTI, ARISTADA, VRAYLAR, CAPLYTA, Jornay PM, INGREZZA, ABILIFY ASIMTUFII, Qelbree.
Industry payments across WY — which companies pay providers there.
